This research paper provides a comprehensive examination of BMP-4 Human Recombinant, a significant member of the bone morphogenetic protein (BMP) family. The paper explores the properties, functions, and mechanisms of BMP-4, along with its synonyms, including BMP4, ZYME, BMP2B, and BMP2B1. The study sheds light on the diverse roles of BMP-4 in development, tissue regeneration, and disease pathogenesis, highlighting its potential therapeutic applications.
BMP-4, or Bone Morphogenetic Protein 4, is a key cytokine belonging to the transforming growth factor-beta (TGF-β) superfamily. It was originally identified for its ability to induce bone formation and plays a critical role in embryonic development, stem cell differentiation, and tissue regeneration. Extensive research has illuminated the multifaceted functions of BMP-4 in various physiological and pathological processes.
2. Structure and Signaling Pathways of BMP-4:
: BMP-4 is a dimeric protein composed of two subunits. It initiates intracellular signaling by binding to specific receptors on the cell surface, leading to the activation of downstream pathways. The canonical BMP signaling pathway involves the phosphorylation of intracellular Smad proteins, which translocate into the nucleus and regulate gene expression. Non-canonical pathways, such as MAPK and PI3K/Akt, are also involved in BMP-4 signaling.
3. Functions of BMP-4 in Development and Regeneration:
BMP-4 is indispensable for embryonic development and morphogenesis. It governs the patterning and differentiation of various tissues and organs, including the skeleton, heart, and nervous system. BMP-4 is crucial for osteoblast differentiation, chondrogenesis, and adipocyte development. Moreover, it participates in tissue repair and regeneration, influencing wound healing and stem cell fate determination.
4. BMP-4 in Disease Pathogenesis:
Dysregulation of BMP-4 signaling has been implicated in several diseases and disorders. Aberrant BMP-4 expression or activity can contribute to developmental defects, such as cleft palate and limb abnormalities. In cancer, BMP-4 has dual roles, acting as both a tumor suppressor and promoter, depending on the tumor type and context. Furthermore, BMP-4 is involved in fibrosis, cardiovascular diseases, and neurodegenerative disorders.
5. Therapeutic Potential of BMP-4 Human Recombinant:
The unique properties of BMP-4 make it an attractive candidate for therapeutic interventions. BMP-4 Human Recombinant, produced through recombinant DNA technology, has been extensively studied for its potential applications. It has shown promise in promoting bone and cartilage regeneration, enhancing wound healing, and stimulating tissue repair in preclinical and clinical studies. Further research is needed to optimize its therapeutic efficacy and safety.
6. Synonyms for BMP-4: BMP4, ZYME, BMP2B, and BMP2B1:
BMP-4 is known by various synonyms in scientific literature and research. These include BMP4, ZYME, BMP2B, and BMP2B1. While BMP-4 is the widely recognized term, knowledge of these alternative designations facilitates efficient literature search and scientific communication among researchers working on BMP-4-related studies.
BMP-4 Human Recombinant, a prominent member of the BMP family, plays diverse roles in development, tissue regeneration, and disease pathogenesis. Understanding its structure, signaling pathways, and synonyms aids in advancing our knowledge of BMP-4’s functions and its therapeutic potential in various fields of medicine.
1. Chen, D., Zhao, M., and Mundy, G. R. (2004). Bone morphogenetic proteins. Growth Factors, 22(4), 233-241.
2. Urist, M. R. (1965). Bone: formation by autoinduction. Science, 150(698), 893-899.
3. Shi, Y., and Massagué, J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 113(6), 685-700.
4. Yang, X., et al. (2021). Bone morphogenetic protein 4: A master regulator of osteogenesis. Biomaterials, 268, 120552.
5. Luo, J., et al. (2016). Roles of bone morphogenetic protein signaling pathway in lipids metabolism. Cell Signaling, 28(6), 423-431.